Mediair Healthcare Products Private Limited, a active private limited company, was established on 07 June 2017 in Mumbai, Maharashtra, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U33100MH2017PTC295924. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.61 Cr.
It upholds a compliant status. Its leadership includes Rohit Mandholia (Director), Alisha Umashankar Mandholia (Director), Meena Mandholia (Director). It holds ₹6.02 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1, Kanti Mahal Chsl, Telli Gali, Opp Imperial Palace Hotel, Andheri East, Mumbai, Maharashtra, 400069.
U33100MH2017PTC295924
295924
07 June 2017
₹5.00 Cr
₹3.61 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Mediair Healthcare Products Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Mandholia | Director | 06 Apr 2022 | Current |
| Alisha Umashankar Mandholia | Director | 26 Mar 2018 | Current |
| Meena Mandholia | Director | 07 Jun 2017 | Current |
| Sanjeev Kumar Mandholia | Director | 07 Jun 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediair Healthcare Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.04% increase. The company also saw a substantial fall in profitability, with a 42.19% decrease in profit. The company's net worth moved up by a moderate rise of 4.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mediair Healthcare Products had a public holding of 36.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹60,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2024 | Others | ₹2.50 Cr | Open |
| 31 May 2024 | Others | ₹3.52 Cr | Open |
Explore comprehensive loan charge details -
Mediair Healthcare Products has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mediair Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediair Healthcare Products's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mediair Healthcare Products Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 2.50 Cr with Charge ID 100965823 was registered on 30 Jun 2024. was completed.
The activity A charge with Others amounted to Rs. 3.52 Cr with Charge ID 100965399 was registered on 31 May 2024. was completed.
Mediair Healthcare Products Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Rohit Mandholia was appointed as a Director was appointed as a Director on 06 Apr 2022 & has been associated with this company since 3 years 7 months . was documented.
The activity Alisha Umashankar Mandholia was appointed as a Director was appointed as a Director on 26 Mar 2018 & has been associated with this company since 7 years 8 months . was completed.
The CIN of Mediair Healthcare Products Private Limited is U33100MH2017PTC295924.
Mediair Healthcare Products Private Limited is headquartered at 1, Kanti Mahal Chsl, Telli Gali, Opp Imperial Palace Hotel, Andheri East, Mumbai, Maharashtra, 400069.
Mediair Healthcare Products Private Limited was incorporated on 07 June 2017.
The current directors of Mediair Healthcare Products Private Limited are
The primary industry of Mediair Healthcare Products Private Limited is Manufacturing.
Mediair Healthcare Products Private Limited is unlisted.
The authorized capital of Mediair Healthcare Products Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.61 Cr.
The compliance status of Mediair Healthcare Products Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX